SCHEMBL26616705

SCHEMBL26616705

COc1nc(Cl)nc2cccc([N+](=O)[O-])c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 10/20 0.47
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 2/20 0.41
MERTK Q12866 1/20 0.41
POLB P06746 2/20 0.39
TYMS P04818 1/20 0.39
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD2 P14416 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRM3 P20309 1/20 0.38
MAOA P21397 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
ADORA2A P29274 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
DRD3 P35462 1/20 0.38
HTR2B P41595 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26616688 0.80 ALDH1A1 (0.44) ALDH1A1TDP1POLBTYMSCHRM2
SCHEMBL16012088 0.75 ALDH1A1 (0.51) ALDH1A1POLB
SCHEMBL26616691 0.74 DCPS (0.41) ALDH1A1KCNH2
SCHEMBL27438102 0.73 MEN1 (0.55) ALDH1A1TDP1POLBTXNRD1TXNRD3
SCHEMBL3107938 0.72 ALDH1A1 (0.49) ALDH1A1TDP1POLBTYMSCHRM2
SCHEMBL2920152 0.71 PIM1 (0.48) PIN1ALDH1A1MERTKPOLBCHRM2
SCHEMBL8779209 0.71 POLB (0.49) ALDH1A1TDP1POLB
SCHEMBL10662992 0.70 ELANE (0.63) ALDH1A1TYMS
SCHEMBL21903868 0.70 TDP1 (0.47) PIN1ALDH1A1TDP1MERTKPOLB
SCHEMBL7681189 0.69 KMT2A (0.46) PIN1ALDH1A1TDP1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348456-A1 QUINAZOLINONES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2023-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348456-A1 QUINAZOLINONES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME CSNK1A1, CSNK1G1, CSNK1G3 PIN1 2706/4885ALDH1A1 3276/4885TDP1 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.